Loading...
DR REDDYS LABORATORIES INC — Tacrolimus Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #14 buyer for Tacrolimus · $1.6M import value · 41 shipments · UNITED STATES · DGFT Verified
DR REDDYS LABORATORIES INC is the #14 importer of Tacrolimus from India with $1.6M in import value and 41 verified shipments. DR REDDYS LABORATORIES INC holds a 1.0% market share in Tacrolimus imports based in UNITED STATES. The company sources from 3 verified suppliers across 30 formulations shipped to 2 countries. Overall, DR REDDYS LABORATORIES INC imports 6 pharmaceutical products worth $9.1M across 5 therapeutic categories.
Verified from 41 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| DR.REDDY'S LABORATORIES LIMITED | $693.9K | 21 | 42.1% |
| DR REDDYS LABORATORIES LIMITED | $500.0K | 10 | 30.4% |
| DR REDDY S LABORATORIES LIMITED | $453.5K | 10 | 27.5% |
DR REDDYS LABORATORIES INC sources Tacrolimus from 3 verified Indian suppliers based on 41 customs records. The primary supplier is DR.REDDY'S LABORATORIES LIMITED accounting for 42.1% of imports.
Buyers ranked immediately above and below #14 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | SANDOZ PTY LTD | AUSTRALIA | $1.9M | 37 | $50.0K |
| 10 | SANDOZ CANADA INC. C/O UPS SCS | CANADA | $1.6M | 33 | $50.0K |
| 14 | DR REDDYS LABORATORIES INC ★ | UNITED STATES | $1.4M | 28 | $50.0K |
| 17 | DR. REDDYS LABORATORIES, INC ★ | UNITED STATES | $1.4M |
Destination countries from 41 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.5M | 38 | 91.0% |
| UNITED STATES OF AMERICA | $147.6K | 3 | 9.0% |
DR REDDYS LABORATORIES INC imports Tacrolimus to 2 countries. The primary destination is UNITED STATES receiving 91.0% of shipments worth $1.5M.
| Formulation | Value | Shipments |
|---|---|---|
| TACROLIMUS CAPSULES USP 1MG 100S 35098X 100S PACKS=3509800 NOS | $150.0K | 3 |
| TACROLIMUS CAPSULES USP 0.5MG 100S 21723 X 100S PACKS=2172300 NOS | $150.0K | 3 |
| TACROLIMUS CAPSULES USP 1MG 100S (17531X 100S PACKS=1753100 NOS) | $103.7K | 3 |
| 300009517 TACROLIMUS CAPSULES USP 1MG 10 | $88.6K | 2 |
| TACROLIMUS CAPSULES USP 1MG 100 S 17460PACKS X 100 S 1746000 NOS | $50.0K | 1 |
| TACROLIMUS CAPSULES USP 1MG 100 S 8736PACKS X 100 S 873600 NOS | $50.0K | 1 |
| TACROLIMUS CAPSULES USP 1MG 100S 8736PACKS X100S 873600 NOS | $50.0K | 1 |
| TACROLIMUS CAPSULES USP 5MG 1608 X 100SPACKS 160800 NOS | $50.0K | 1 |
What DR REDDYS LABORATORIES INC and other importers must comply with to import Tacrolimus from India
U.S. Food and Drug Administration (FDA)
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
India exported $51.0M worth of Tacrolimus through 4,611 shipments from 299 suppliers to 127 countries, serving 727 buyers globally. DR REDDYS LABORATORIES INC imports $1.6M of this total, accounting for 1.0% of India's Tacrolimus exports with 41 shipments from UNITED STATES. This is verified from 41 customs shipment records covering 30 distinct formulations.
DR REDDYS LABORATORIES INC's average Tacrolimus order value is $40.2K per consignment, based on 41 shipments totaling $1.6M. DR REDDYS LABORATORIES INC is based in UNITED STATES and ranks #14 among all Tacrolimus importers from India by value. The company sources from 3 verified suppliers in India.
DR REDDYS LABORATORIES INC sources Tacrolimus from 3 verified Indian suppliers: DR.REDDY'S LABORATORIES LIMITED ($693.9K, 42.1%), DR REDDYS LABORATORIES LIMITED ($500.0K, 30.4%), DR REDDY S LABORATORIES LIMITED ($453.5K, 27.5%). This is based on 41 customs records.
DR REDDYS LABORATORIES INC ranks #14 among 727 Tacrolimus importers from India with a 1.0% market share. The top 3 importers are LEK D.D ($9.8M), SANDOZ INC. C/O EXEL, INC. ($9.6M), EVERSANA LIFE SCIENCES SERVICES,LLC ($7.1M). DR REDDYS LABORATORIES INC processed 41 shipments from UNITED STATES.
DR REDDYS LABORATORIES INC imports 6 products worth $9.1M. Beyond Tacrolimus, top products include Metoprolol, Clopidogrel, Doxorubicin, Ciprofloxacin, Dexamethasone. View the complete DR REDDYS LABORATORIES INC profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Tacrolimus — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for DR REDDYS LABORATORIES INC's Tacrolimus imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
DR REDDYS LABORATORIES INC
Full Company Profile →
6 products · $9.1M total trade · 5 categories
| 28 |
| $50.0K |
| 13 | GLENMARK PHARMACEUTICALS INC | UNITED STATES | $1.3M | 26 | $50.0K |
DR REDDYS LABORATORIES INC ranks #14 among 727 Tacrolimus importers from India. Average shipment value of $50.0K compared to the market average of $70.2K. The closest competitors by value are SANDOZ PTY LTD and SANDOZ CANADA INC. C/O UPS SCS.
| TACROLIMUS CAPSULES USP 1MG 100S 8736 |
| $50.0K |
| 1 |
| 300009517 TACROLIMUS CAPSULES USP 1MG 100S (26256 SU X 100=2625600 NOS) | $50.0K | 1 |
DR REDDYS LABORATORIES INC imports 30 distinct Tacrolimus formulations from India. The top formulation is TACROLIMUS CAPSULES USP 1MG 100S 35098X 100S PACKS=3509800 N with 3 shipments worth $150.0K.
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 127+ countries, 727+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for DR REDDYS LABORATORIES INC.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Tacrolimus. For current order-level data, contact TransData Nexus.